Clinical, regulatory, and payer records, before outcomes appear.
Healthcare value is shaped before commercial outcomes appear. Trials, regulatory decisions, safety updates, label changes, access decisions, and payer rules all create early evidence about whether a therapy, sponsor, or market is gaining or losing momentum.
Which programs are advancing, weakening, or nearing a catalyst?
Trials, FDA filings, disclosures, endpoints, and indications.
When will this read out, and will it slip?
Trial status, enrollment, completion dates, and endpoint changes.
Will this clear the FDA, and on what timeline?
Approvals, CRLs, advisory committees, designations, and labels.
Is this commercially viable, and is a safety signal forming?
CMS and payer decisions, pricing, FAERS, and post-market records.
Expert-grade analysis for the most critical decisions, benchmarked head-to-head against frontier models.
Read the benchmarkThe same clinical, regulatory, safety, and payer records, watched the way your team would. You decide what matters; the platform catches it, explains what changed, and flags what it could mean next.
Name the change you need to catch before the market does. See it running on the record.